Editorial: Bush must act where Congress failed in bioterror work

12/28/2005 | Washington Times, The

Congress has been stalling for more than four years on legislation aimed at using genomics to develop ways to detect disease outbreaks and develop countering drugs quickly in mass quantities, The Washington Times says in an editorial. Public interest groups have blocked congressional efforts to encourage bioterror work, such as protecting vaccine-makers from lawsuits, allowing accelerated review by the FDA and sharing of clinical trial data, the editorial writers assert. As such, the president needs to "act decisively to protect the nation if Congress cannot," the writers conclude.

View Full Article in:

Washington Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD